FGF21 and metabolic dysfunction-associated steatohepatitis: FGF21 may be able to affect the proliferation of hepatocellular carcinoma cells, as lack of FGF21 has been reported to promote liver cancer associated with metabolic stress such as long-term obesogenic diet feeding or nonalcoholic steatohepatitis (16, 17).